Mobile

An open label, prospective, pharmacokinetic/pharmacodynamic and safety evaluation of oseltamivir (Tamiflu) in the treatment of infants 0 to <12 months of age with laboratory confirmed influenza infect...

Update Il y a 4 ans
Reference: EUCTR2009-014365-12

An open label, prospective, pharmacokinetic/pharmacodynamic and safety evaluation of oseltamivir (Tamiflu) in the treatment of infants 0 to <12 months of age with laboratory confirmed influenza infection

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective is to define the pharmacokinetics of oseltamivir and oseltamivir carboxylate in children with confirmed influenza up to one year of age.

Inclusion criteria

  • Treatment of influenza

Links